Structure-based design of HIV protease inhibitors: Sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors

被引：89
|
作者：
Thaisrivongs, S
Skulnick, HI
Turner, SR
Strohbach, JW
Tommasi, RA
Johnson, PD
Aristoff, PA
Judge, TM
Gammill, RB
Morris, JK
Romines, KR
Chrusciel, RA
Hinshaw, RR
Chong, KT
Tarpley, WG
Poppe, SM
Slade, DE
Lynn, JC
Horng, MM
Tomich, PK
Seest, EP
Dolak, LA
Howe, WJ
Howard, GM
Schwende, FJ
Toth, LN
Padbury, GE
Wilson, GJ
Shiou, LH
Zipp, GL
Wilkinson, KF
Rush, BD
Ruwart, MJ
Koeplinger, KA
Zhao, ZY
Cole, S
Zaya, RM
Kakuk, TJ
Janakiraman, MN
Watenpaugh, KD
机构：
[1] SAMC, Pharmacia and Upjohn, Inc., Kalamazoo
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 1996年 / 39卷 / 22期
关键词：
D O I：
10.1021/jm960541s
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：4349 / 4353
页数：5
相关论文
共 50 条
  • [21] Oxidative Degradation of a Sulfonamide-Containing 5,6-Dihydro-4-Hydroxy-2-Pyrone in Aqueous/Organic Cosolvent Mixtures
    Susan W. Hovorka
    Michael J. Hageman
    Christian Schöneich
    Pharmaceutical Research, 2002, 19 : 538 - 545
  • [22] Structure-based discovery of non-peptidic small molecule inhibitors of Caspase-3
    Sakai, J
    Yoshimori, A
    Takasawa, R
    Tanuma, SI
    FEBS JOURNAL, 2005, 272 : 522 - 522
  • [23] Modification and biological evaluation of novel 4-hydroxy-pyrone derivatives as non-peptidic HIV-1 protease inhibitors
    Meizi He
    Ning Yang
    Chunlai Sun
    Xiaojian Yao
    Ming Yang
    Medicinal Chemistry Research, 2011, 20 : 200 - 209
  • [24] Modification and biological evaluation of novel 4-hydroxy-pyrone derivatives as non-peptidic HIV-1 protease inhibitors
    He, Meizi
    Yang, Ning
    Sun, Chunlai
    Yao, Xiaojian
    Yang, Ming
    MEDICINAL CHEMISTRY RESEARCH, 2011, 20 (02) : 200 - 209
  • [25] STRUCTURE-BASED DESIGN OF NOVEL NONPEPTIDIC HIV PROTEASE INHIBITORS
    LOVASZ, KD
    MORRIS, JK
    TOMICH, PK
    WATENPAUGH, KD
    HOWE, WJ
    DOLAK, LA
    ROMINES, KR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 25 - MEDI
  • [26] Structure-based drug design of HIV protease inhibitors.
    Navia, MA
    Tung, RD
    Chaturvedi, PR
    Rao, BG
    Partaledis, JA
    Kim, EE
    FASEB JOURNAL, 1996, 10 (06): : 2436 - 2436
  • [27] Synthesis of 5,6-dihydro-4-hydroxy-2-pyrones via formal hetero diels-alder reactions.
    Liu, K
    Xu, L
    Jones, AB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U189 - U189
  • [28] Asymmetric syntheses and absolute streochemistry of 5,6-dihydro-α-pyrones, A new class of potent HIV protease inhibitors
    Judge, T.M.
    Phillips, G.
    Morris, J.K.
    Lovasz, K.D.
    Romines, K.R.
    Luke, G.P.
    Tulinsky, J.
    Tustin, J.M.
    Chrusciel, R.A.
    Dolak, L.A.
    Mizsak, S.A.
    Watt, Mizsak W.
    Morris, J.
    Vander Velde, S.L.
    Strohbach, J.W.
    Gammill, R.B.
    Journal of the American Chemical Society, 1997, 119 (15):
  • [29] Structure-based design of non-peptidic pyridone aldehydes as inhibitors of interleukin-1 beta converting enzyme.
    Golec, JMC
    Mullican, MD
    Murcko, MA
    Wilson, KP
    Kay, DP
    Jones, SD
    Murdoch, R
    Bemis, GW
    Raybuck, SA
    Luong, YP
    Livingston, DJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (17) : 2181 - 2186
  • [30] 6-PHENYL-6-ALKYLAMIDO-5,6-DIHYDRO-2H-PYRONES - NOVE HIV PROTEASE INHIBITORS
    HAMILTON, HW
    TAIT, BD
    FERGUSON, D
    LUNNEY, EA
    TUMMINO, PJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 23 - MEDI
12345